Letter by Taegtmeyer and Khalaf Regarding Article, “Glucose-Insulin-Potassium Reduces the Incidence of Low Cardiac Output Episodes After Aortic Valve Replacement for Aortic Stenosis in Patients With Left Ventricular Hypertrophy: Results From the Hypertrophy, Insulin, Glucose, and Electrolytes (HINGE) Trial”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To The Editor:
We read with interest the article by Howell et al.1 We wish to offer some brief comments. Although the concept has been around for nearly 50 years, glucose-insulin-potassium still lacks an established protocol.
Uncertainties surrounding glucose-insulin-potassium are, in part, due to the different contexts, doses, timing, and protocols used.1 The clinical cardiologist may inquire about the rationale for the investigators' choice of the specific protocol used in the Hypertrophy, …